Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Abstract The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibi...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/4e45db775cc64c1a91f4546776fa7729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|